Skip to main content
Top

Pathology & Oncology Research

Issue 1/1998

Content (13 Articles)

Article

P53 Expression in stage I squamous cell lung cancer

Judit Moldvay, János Strausz, Márta EgervÁry, László AgÓcs, József Bocsi, Zsuzsa Schaff

Article

Expression of invasion markers CD44v6/v3, NM23 and MMP2 in laryngeal and hypopharyngeal carcinoma

Gábor RÉPÁssy, Csaba Forster-HorvÁth, Attila JuhÁsz, Róza ÁDÁny, Anna TamÁssy, József TÍmÁr

Article

Cellular alterations upon IR-Laser (890 nm) exposures,In Vivo

Antonina I Kolesnikova, Tamara Kubasova, Anatolij G Konoplyannikov, György J KÖteles

Article

Embryotoxicity and teratogenicity of some derivatives of chloroethylaminophenylacetic acid

Violeta ŽalgevicienÉ, Janina ŽUkienÉ, Gražina GraŽElienÉ, Giedre SinkeviČiÚtÉ, Janina DidŽiapetrienÉ

Article

Comparison of the effects of the antimetastatic compound ImH[trans-RuCl4(DMSO)Im] (NAMI-A) on the arthritic rat and on MCa mammary carcinoma in mice

Gianni Sava, Renato Gagliardi, Moreno Cocchietto, Katiuscia CLERICI, Ilaria Capozzi, Mauro Marrella, Enzo Alessio, Giovanni Mestroni, Roberto Milanino

Case Report

Coronary vasculopathy in polycythemia vera

Benita Hermanns, Stefan Handt, Joachim Kindler, László FÜzesi

Case Report

Carcinoid tumor of the middle ear in a 28-year-old patient

Hendrik BlÄker, Gerhard Dyckhoff, Hagen Weidauer, Herwart F Otto

Case Report

Intravenous Leiomyomatosis of the Uterus

Liliana Ala Andrade, Renato Z Torres An, José Fs Sales, Regina Vicentini, Gustavo A De Souza

Case Report

Biclonal primary plasma cell leukemia

Zoltán TÓth, József Sipos

Special Report

Plasma HIV-1 load and disease progression in HIV-Infected patients in Hungary

Judit Segesdi, Ágnes Gyuris, Dénes BÁnhegyi, Dalma VÖdrÖs, Ágnes Bakos, János MinÁrovits

Special Report

Studies on the antibodies to human herpesvirus type 6 among Hungarian patients with asymptomatic HIV infection

Csaba László MarÓdi, Anna CsiszÁr, Beatriz SIerra-Vazquez, Dario DI Luca, Éva BarabÁs, Károly Nagy, Joseph OngrÁdi

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine